GlassScriptPhysician profile
Michael Dolphin
NPI 1588635502
$47,781.26
in general payments reported to CMS, 2019-2025
15 companies · $1,437 in 2025
The $1,437 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,070 · 2020: $398 · 2021: $13K · 2022: $16K · 2023: $3,544 · 2024: $12K · 2025: $1,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,000 · Food and Beverage: $3,770 · Travel and Lodging: $3,451 · Education: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,000.00 |
| Food and Beverage | $3,770.45 |
| Travel and Lodging | $3,450.61 |
| Education | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $34,470.37 | 2019-2023 | Xlif, Alif, Brigade |
| Globus Medical, INC. | $8,619.06 | 2024-2025 | Xlif, Alif, Excelsius Gps |
| Prism Medical | $1,697.12 | 2024 | |
| Wardlow Enterprises | $1,236.85 | 2024 | |
| Arthrex, INC. | $1,108.20 | 2024 | |
| Augmedics INC. | $169.78 | 2025 | Xvision |
| Stryker Corporation | $130.80 | 2021-2025 | Mako |
| Convatec INC. | $96.25 | 2024 | |
| Ethicon US, LLC | $53.39 | 2025 | Dermabond Prineo |
| Ferring Pharmaceuticals INC. | $52.30 | 2023-2025 | Euflexxa |
| Pacira Therapeutics, INC. | $50.61 | 2021 | |
| Orthofix Medical, INC. | $39.27 | 2021-2025 | Spinal-Stim, Spinal-Stim, Cervical-Stim |
| Biocomposites INC | $27.33 | 2025 | Stimulan |
| Depuy Synthes Sales INC. | $15.14 | 2025 | Na, Va-Lcp |
| Bioventus LLC | $14.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dolphin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.